Clinical Trials List
2008-01-01 - 2010-01-01
Phase II
Terminated5
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- Yu-Chieh Tsai Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- 黃敬倫 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- 林璟宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yee Chao Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
64 participants
